MarketCap
Facebook
X
Telegram
Axonics Modulation Technologies Net Income | AXNX
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Axonics Modulation Technologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.09 M | -59.7 M | -80.1 M | -54.9 M | -79.9 M | -32.5 M | -18.1 M | -17.4 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -6.09 M | -80.1 M | -43.6 M |
Quarterly Net Income Axonics Modulation Technologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -21 K | 6.9 M | -19.1 M | - | 3.93 M | -7.34 M | -9.25 M | - | -16.3 M | -21.4 M | -22.7 M | - | -17.2 M | -25.1 M | -22.5 M | - | -9.17 M | -19.8 M | -14.6 M | - | -25 M | -19.1 M | -13.1 M | - | -7.57 M | -8.65 M | -6.6 M | - | -4.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.9 M | -25.1 M | -12.6 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Medical devices industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
410 M | $ 153.68 | 1.9 % | $ 11.1 B |  USA |
 |
Apyx Medical Corporation
APYX
|
-11.2 M | $ 2.94 | 1.38 % | $ 121 M | USA |
 |
Alphatec Holdings
ATEC
|
-143 M | $ 10.79 | 1.98 % | $ 1.62 B | USA |
 |
Inari Medical
NARI
|
-1.64 M | - | - | $ 4.23 B | USA |
 |
AxoGen
AXGN
|
-15.7 M | $ 43.57 | 3.33 % | $ 2.01 B | USA |
 |
Bruker Corporation
BRKR
|
-8.3 M | $ 52.5 | 0.19 % | $ 7.97 B | USA |
 |
Boston Scientific Corporation
BSX
|
2.89 B | $ 45.06 | 4.84 % | $ 66.7 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-638 K | $ 8.3 | 3.43 % | $ 605 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
-25.5 M | $ 13.56 | 0.18 % | $ 384 M | USA |
 |
CONMED Corporation
CNMD
|
47.1 M | $ 46.62 | 0.69 % | $ 1.45 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-8.2 M | $ 6.07 | 0.63 % | $ 378 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-70.8 M | $ 5.9 | 2.46 % | $ 797 M | USA |
 |
Electromed
ELMD
|
11.3 M | $ 26.56 | 0.4 % | $ 220 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-51.1 M | $ 71.77 | 1.17 % | $ 2.13 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
1.07 B | $ 85.93 | 1.85 % | $ 50.3 B | USA |
 |
Globus Medical
GMED
|
538 M | $ 75.39 | 1.62 % | $ 10.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
-40.9 M | $ 2.28 | 2.7 % | $ 50.3 M | USA |
 |
Inogen
INGN
|
22.7 M | $ 5.28 | 0.09 % | $ 140 M | USA |
 |
InMode Ltd.
INMD
|
93.8 M | $ 14.88 | 0.2 % | $ 962 M | Israel |
 |
Abbott Laboratories
ABT
|
6.52 B | $ 102.99 | 1.02 % | $ 179 B | USA |
 |
IRIDEX Corporation
IRIX
|
-4.44 M | $ 0.65 | 0.74 % | $ 11 M | USA |
 |
IRadimed Corporation
IRMD
|
22.5 M | $ 82.87 | 0.79 % | $ 1.05 B | USA |
 |
Integer Holdings Corporation
ITGR
|
103 M | $ 126.19 | 0.15 % | $ 4.38 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.6 M | $ 22.32 | 1.16 % | $ 524 M | USA |
 |
LivaNova PLC
LIVN
|
-242 M | $ 79.62 | 1.84 % | $ 4.34 B |  Britain |
|
LENSAR
LNSR
|
-34.3 M | $ 7.87 | 3.55 % | $ 94.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
-54 M | $ 1.98 | 6.76 % | $ 80.6 M | USA |
 |
Medtronic PLC
MDT
|
4.8 B | $ 93.77 | 3.08 % | $ 120 B | USA |
 |
MiMedx Group
MDXG
|
48.6 M | $ 4.58 | 0.11 % | $ 677 M | USA |
 |
Myomo
MYO
|
-15.6 M | $ 1.29 | 1.17 % | $ 54 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-75 M | $ 0.72 | 2.03 % | $ 46.6 M | Israel |
 |
InspireMD
NSPR
|
-48.8 M | $ 0.81 | 2.13 % | $ 52.1 M | Israel |
 |
Orthofix Medical
OFIX
|
-92.2 M | $ 9.01 | 0.86 % | $ 357 M |  Curacao |
 |
Outset Medical
OM
|
-81.7 M | $ 3.18 | 0.31 % | $ 48.4 K | USA |
 |
PAVmed
PAVM
|
-3.77 M | $ 4.21 | 0.72 % | $ 2.82 M | USA |
 |
Penumbra
PEN
|
178 M | $ 320.04 | 0.73 % | $ 12.5 B | USA |
 |
Insulet Corporation
PODD
|
247 M | $ 137.17 | 3.95 % | $ 9.65 B | USA |
 |
Profound Medical Corp.
PROF
|
-42.6 M | $ 5.86 | 0.17 % | $ 177 M |  Canada |
 |
Quanterix Corporation
QTRX
|
-107 M | $ 2.44 | 2.15 % | $ 104 M | USA |
 |
AVITA Medical
RCEL
|
-48.6 M | $ 10.34 | 4.66 % | $ 288 M |  Australia |
 |
Sintx Technologies
SINT
|
-10.4 M | $ 1.74 | 2.2 % | $ 4.83 M | USA |
 |
Smith & Nephew plc
SNN
|
625 M | $ 28.44 | 3.42 % | $ 24.7 B | Britain |
 |
Sensus Healthcare
SRTS
|
-7.72 M | $ 3.13 | 0.16 % | $ 51.1 M | USA |
 |
Stryker Corporation
SYK
|
849 M | $ 283.31 | 2.81 % | $ 108 B | USA |
 |
TELA Bio
TELA
|
-38.8 M | $ 1.02 | 5.15 % | $ 47.9 M | USA |
 |
TransMedics Group
TMDX
|
190 M | $ 88.05 | 7.14 % | $ 2.99 B | USA |
 |
Tandem Diabetes Care
TNDM
|
-205 M | $ 16.97 | 0.06 % | $ 1.15 B | USA |
 |
BIOLASE
BIOL
|
-20.6 M | - | -13.19 % | $ 166 K | USA |
 |
Viemed Healthcare
VMD
|
15.4 M | $ 8.81 | 0.17 % | $ 343 M | USA |